Aaa Usa Inc Drug Patent Portfolio
Aaa Usa Inc owns 2 orange book drugs protected by 7 US patents Given below is the list of Aaa Usa Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10596276 | Stable, concentrated radionuclide complex solutions | 25 Jan, 2039 | Active |
| US10596278 | Stable, concentrated radionuclide complex solutions | 25 Jan, 2039 | Active |
| US11904027 | Stable, concentrated radionuclide complex solutions | 25 Jan, 2039 | Active |
| US10596276 | Stable, concentrated radionuclide complex solutions | 25 Jul, 2038 | Active |
| US10596278 | Stable, concentrated radionuclide complex solutions | 25 Jul, 2038 | Active |
| US11904027 | Stable, concentrated radionuclide complex solutions | 25 Jul, 2038 | Active |
| US9375498 | Process for the preparation of complexes of 68Ga | 10 Aug, 2032 | Active |
Latest Legal Activities on Aaa Usa Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aaa Usa Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail Patent eGrant Notification | 20 Feb, 2024 | US11904027 |
| Recordation of Patent eGrant | 20 Feb, 2024 | US11904027 |
|
Email Notification
Critical
| 20 Feb, 2024 | US11904027 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Feb, 2024 | US11904027 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Feb, 2024 | US11904027 |
| Patent eGrant Notification | 20 Feb, 2024 | US11904027 |
|
Email Notification
Critical
| 01 Feb, 2024 | US11904027 |
|
Issue Notification Mailed
Critical
| 31 Jan, 2024 | US11904027 |
| Dispatch to FDC | 17 Jan, 2024 | US11904027 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Dec, 2023 | US9375498 |
|
Issue Fee Payment Received
Critical
| 05 Oct, 2023 | US11904027 |
|
Issue Fee Payment Verified
Critical
| 05 Oct, 2023 | US11904027 |
|
Mail Notice of Allowance
Critical
| 03 Oct, 2023 | US11904027 |
|
Notice of Allowance Data Verification Completed
Critical
| 29 Sep, 2023 | US11904027 |
|
Information Disclosure Statement considered
Critical
| 26 Sep, 2023 | US11904027 |
Aaa Usa Inc's Drug Patent Litigations
Aaa Usa Inc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Oct 02, 2020, against patent number US10596278. The petitioner Evergreen Theragnostics, Inc., challenged the validity of this patent, with Advanced Accelerator Applications SA as the respondent. Click below to track the latest information on how companies are challenging Aaa Usa Inc's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US10596276 | October, 2020 |
Institution Denied
(14 Apr, 2021)
| Advanced Accelerator Applications SA | Evergreen Theragnostics, Inc. |
| US10596278 | October, 2020 |
Terminated-Denied
(14 Apr, 2021)
| Advanced Accelerator Applications SA | Evergreen Theragnostics, Inc. |
Aaa Usa Inc's Family Patents
Aaa Usa Inc Drug List
Given below is the complete list of Aaa Usa Inc's drugs and the patents protecting them.
1. Lutathera
Lutathera is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10596276
(Pediatric)
| Stable, concentrated radionuclide complex solutions |
25 Jan, 2039
(14 years from now)
| Active |
| US10596278
(Pediatric)
| Stable, concentrated radionuclide complex solutions |
25 Jan, 2039
(14 years from now)
| Active |
| US11904027
(Pediatric)
| Stable, concentrated radionuclide complex solutions |
25 Jan, 2039
(14 years from now)
| Active |
| US10596276 | Stable, concentrated radionuclide complex solutions |
25 Jul, 2038
(13 years from now)
| Active |
| US10596278 | Stable, concentrated radionuclide complex solutions |
25 Jul, 2038
(13 years from now)
| Active |
| US11904027 | Stable, concentrated radionuclide complex solutions |
25 Jul, 2038
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lutathera's drug page
2. Netspot
Netspot is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9375498 | Process for the preparation of complexes of 68Ga |
10 Aug, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Netspot's drug page